Pair Name | Costunolide, Doxorubicin | ||
Phytochemical Name | Costunolide (PubChem CID: 5281437 ) | ||
Anticancer drug Name | Doxorubicin (PubChem CID: 31703 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Costunolide, Doxorubicin | |||
Disease Info | [ICD-11: 2C82] | Prostate cancer | Investigative | |
Biological Phenomena | Induction-->ROS generation | |||
Gene Regulation | Up-regulation | Phosphorylation | MAPK14 | hsa1432 |
Up-regulation | Phosphorylation | MAPK8 | hsa5599 | |
Up-regulation | Expression | ROS1 | hsa6098 | |
In Vitro Model | DU145 | Prostate carcinoma | Homo sapiens (Human) | CVCL_0105 |
PC-3 | Prostate carcinoma | Homo sapiens (Human) | CVCL_0035 | |
In Vivo Model | PC-3 cells (3×10⁶) were injected subcutaneously into the armpit of each mouse. | |||
Result | We suggested that costunolide in combination with doxorubicin was a new potential chemotherapeutic strategy for treating prostate cancer. |
Pair Name | Costunolide, Doxorubicin | |||
Disease Info | [ICD-11: 2B33.3] | Acute lymphoblastic leukemia | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Down-regulation | Phosphorylation | PIK3CA | hsa5290 | |
In Vitro Model | K-562 | Blast phase chronic myelogenous leukemia | Homo sapiens (Human) | CVCL_0004 |
Result | These results demonstrate that costunolide may be a potent therapeutic agent against chronic myeloid leukemia. |
No. | Title | Href |
---|---|---|
1 | Costunolide enhances doxorubicin-induced apoptosis in prostate cancer cells via activated mitogen-activated protein kinases and generation of reactive oxygen species. Oncotarget. 2017 Nov 21;8(64):107701-107715. doi: 10.18632/oncotarget.22592. | Click |
2 | Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway. Phytother Res. 2019 Jun;33(6):1683-1688. doi: 10.1002/ptr.6355. | Click |